Press release
Wet Age-Related Macular Degeneration Treatment Drugs, Pipeline Insights Report 2024
Wet Age-Related Macular Degeneration Pipeline
Explore our latest breakthroughs in Wet Age-Related Macular Degeneration Research. Learn more about our innovative pipeline today! @ Wet Age-Related Macular Degeneration Pipeline Outlook-= https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Wet Age-Related Macular Degeneration Pipeline Report
• August 2024:- Outlook Therapeutics Inc.:- Safety and Effectiveness of ONS-5010 Compared to Lucentis® in Subjects With Neovascular Age-related Macular Degeneration; NORSE EIGHT. Multicenter, randomized, masked, controlled study of the safety and effectiveness of intravitreally administered ONS-5010.
• DelveInsight's Wet Age-Related Macular Degeneration pipeline report depicts a robust space with 70+ active players working to develop 75+ pipeline therapies for Wet Age-Related Macular Degeneration treatment.
• The leading Wet Age-Related Macular Degeneration Companies such as OliX Pharmaceuticals, Frontera Therapeutics, Kyowa Kirin, Boehringer Ingelheim, Clearside Biomedical, PanOptica, EyePoint Pharmaceuticals, Unity Biotechnology, AngioLab, Kinarus Therapeutics, Sylentis, Mabwell (Shanghai) Bioscience, Samsung Bioepis, Sandoz, Outlook Therapeutics, Molecular Partners, Sam Chun Dang Pharm, TOT Biopharm, and others.
• Promising Wet Age-Related Macular Degeneration Pipeline Therapies in the various stages of development include Aflibercept (Eylea, BAY86-5321), Eyp-1901, NG101 AAV gene therapy, CMAB818, Lucentis®, RC28-E, Aflibercept, Ranibizumab, SCT510A, SCD411, Aflibercept, and others.
Stay informed about the cutting-edge advancements in Wet Age-Related Macular Degeneration Treatments. Download for updates and be a part of the revolution in cancer care @ Wet Age-Related Macular Degeneration Clinical Trials Assessment- https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Wet Age-related Macular Degeneration Emerging Drugs
• RGX-314: REGENXBIO
RGX-314 is a one-time subretinal treatment that includes the NAV AAV8 vector containing a gene encoding for a monoclonal antibody fragment. The expressed protein is designed to neutralize vascular endothelial growth factor (VEGF) activity, modifying the pathway for the formation of new leaky blood vessels and retinal fluid accumulation. RGX-314 is being developed as a potentially one-time treatment for wet AMD, diabetic retinopathy, and other additional chronic retinal conditions treated with anti-VEGF.
• 9MW 0211: Mabwell (Shanghai) Bioscience
9MW 0211 is a recombinant anti-VEGF humanized monoclonal antibody obtained based on rabbit monoclonal antibody and humanized transformation technology, which is a category 1 therapeutic biological product. It can specifically bind to the most active VEGF-A in the VEGF family, block its binding to receptors on the surface of endothelial cells, reduce vascular permeability and block the formation and development of new blood vessels, and reduce the leakage caused by new blood vessels, so as to achieve the purpose of treating eye diseases related to neovascularization such as neovascular (wet) age-related macular degeneration. The drug is currently being evaluated in Phase II/III clinical trial to treat patients with wet-AMD.
• SYL1801: Sylentis
SYL1801 is a chemically modified siRNA, engineered using Sylentis proprietary SirFinder, which inhibits the synthesis of Nrarp. It is administered as an eye drop solution to transcriptionally down-regulate the expression of Nrarp, a target different from those against which the usual anti-angiogenic therapies based on anti-VEGF agents are directed. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with wet AMD.
• OLX10212: OliX Pharmaceuticals
OLX10212 is a novel cell penetrating asymmetric small interference RNA being developed by OliX Pharmaceuticals in Phase I stage of development for the treatment of wet-MAD. OLX10212 targets inflammation pathways that play a key role in the development of geographic atrophy (GA) and neovascular AMD.
Learn more about Wet Age-Related Macular Degeneration Drugs opportunities in our groundbreaking Wet Age-Related Macular Degeneration Research and development projects @ Wet Age-Related Macular Degeneration Unmet Needs- https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Wet Age-related Macular Degeneration pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Intravenous
• Subcutaneous
• Oral
• Intramuscular
Wet Age-Related Macular Degeneration Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide
Discover the latest advancements in Wet Age-Related Macular Degeneration Treatment by visiting our website. Stay informed about how we're transforming the future of oncology @ Wet Age-Related Macular Degeneration Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Wet Age-Related Macular Degeneration Companies and Therapies
• Neuracle Genetics Inc.: NG101 AAV gene therapy
• RemeGen Co. Ltd:- RC28-E
• Outlook Therapeutics Inc.:- Bevacizumab/Ranibizumab
Scope of the Wet Age-Related Macular Degeneration Pipeline Report
• Coverage- Global
• Wet Age-Related Macular Degeneration Companies- OliX Pharmaceuticals, Frontera Therapeutics, Kyowa Kirin, Boehringer Ingelheim, Clearside Biomedical, PanOptica, EyePoint Pharmaceuticals, Unity Biotechnology, AngioLab, Kinarus Therapeutics, Sylentis, Mabwell (Shanghai) Bioscience, Samsung Bioepis, Sandoz, Outlook Therapeutics, Molecular Partners, Sam Chun Dang Pharm, TOT Biopharm, and others.
• Wet Age-Related Macular Degeneration Pipeline Therapies- Aflibercept (Eylea, BAY86-5321), Eyp-1901, NG101 AAV gene therapy, CMAB818, Lucentis®, RC28-E, Aflibercept, Ranibizumab, SCT510A, SCD411, Aflibercept, and others.
• Wet Age-Related Macular Degeneration Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Wet Age-Related Macular Degeneration Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
For a detailed overview of our latest research findings and future plans, read the full details of Wet Age-Related Macular Degeneration Pipeline on our website @ Wet Age-Related Macular Degeneration Drugs and Companies- https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Wet Age-related Macular Degeneration: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Wet Age-related Macular Degeneration- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. RGX-314: REGENXBIO
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. SYL1801: Sylentis
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. OLX10212: OliX Pharmaceuticals
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug Name: Company Name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Wet Age-related Macular Degeneration- Unmet Needs
21. Wet Age-related Macular Degeneration- Market Drivers and Barriers
22. Appendix
List of Top Selling Market Research Reports in 2024
Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Yash Bhardwaj
info@delveinsight.com
+91-9650213330
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wet Age-Related Macular Degeneration Treatment Drugs, Pipeline Insights Report 2024 here
News-ID: 3645529 • Views: …
More Releases from DelveIinsight
Lou Gehrig's Disease Pipeline: 75+ Innovators Pioneering Breakthrough Therapies …
The Lou Gehrig's Disease market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Denali Therapeutics, AbbVie, Calico Life Sciences, and Clene Nanomedicine Biosciences. These industry pioneers are transforming treatment strategies and redefining the future of Lou Gehrig's Disease, bringing new hope to patients worldwide.
DelveInsight's "Lou Gehrig's Disease Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Lou…
Herpes Labialis Clinical Pipeline |6+ Companies Driving the Next Generation of T …
The Herpes Labialis market is rapidly advancing, fueled by groundbreaking research and innovative therapies from companies such as AiCuris, Heidelberg ImmunoTherapeutics, and Ecogene 21. These industry pioneers are transforming treatment strategies and redefining the future of Herpes Labialis care, bringing new hope to patients worldwide.
DelveInsight's 'Herpes Labialis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline Herpes Labialis therapies in various stages of clinical development. Major pharmaceutical companies are…
Microbiome Disease Clinical Pipeline | 140+ Companies Advancing Next-Generation …
The microbiome disease market is experiencing rapid growth and is driven by groundbreaking research and cutting-edge therapies. Industry leaders like MaaT Pharma, Qu Biologics, Biomica Ltd., and Seres Therapeutics are pioneering innovative treatment strategies, reshaping the landscape of microbiome-based therapeutics. As these transformative therapies progress through clinical development, they offer new hope for patients worldwide, redefining the future of microbiome disease management.
DelveInsight's 'Microbiome Disease Pipeline Insight 2025' report provides comprehensive…
Metastatic Renal Cell Carcinoma Clinical Pipeline | Over 40 Companies Driving th …
The Metastatic Renal Cell Carcinoma market is rapidly evolving with cutting-edge research and breakthrough therapies driven by leading companies like AstraZeneca, Genentech, Sumitomo Dainippon Pharma, and Allogene Therapeutics. These innovators are revolutionizing treatment approaches and shaping the future of Metastatic Renal Cell Carcinoma care, offering new hope for patients worldwide.
DelveInsight's 'Metastatic Renal Cell Carcinoma Pipeline Insight 2025' report provides comprehensive global coverage of pipeline Metastatic Renal Cell Carcinoma therapies in…
More Releases for Wet
Global Wet Cat Food Market and Trends
According to a new report published by Allied Market Research, titled, "Wet Cat Food Market by Product Type, End User, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030," The lockdown across various countries and ban on international travel has disrupted the supply chain and revenue chain.
The global wet cat food market size was valued at $4.6 billion in 2020, and is projected to reach $7.9 billion by 2030,…
Oscillation Flowmeters for Dry and Wet Gases
Oscillation is a measurement method that is unique for gases and can be used in a variety of ways for flow measurement with the aid of a flow oscillator. With this unique measuring method, a partial flow of the medium is passed through a bypass into the oscillator. In the oscillator, the medium flows through a chamber with two flow channels. A bluff body deflects the flow either in one…
Emirates Wet Wipes Partners with Medialinks
Emirates Wet Wipes, one of the largest hygiene care products manufacturers in the GCC, is ramping up its advertising and brand direction with the appointment of integrated digital & ecommerce agency, Medialinks, to its pan-Arab business.
Medialinks will be EWW’s first retained agency to oversee company’s entire digital account, which will encompass a fully optimized website, advertising, social, search engine optimisation and analytics.
The appointment happened after three-month competitive pitch process.…
Cross Fold Wet Tissue Market|| Worldwide, 2030
The “Cross Fold Wet Tissue Market Analysis to 2030” is a specialized and in-depth study of the Cross Fold Wet Tissue industry with a focus on the Cross Fold Wet Tissue market trend. The report aims to provide an overview of the Cross Fold Wet Tissue market with detailed market segmentation by component, application, end-user, and geography. The Cross Fold Wet Tissue market is expected to witness high growth during…
Global Cat Wet Food Market 2017 - NORY, WIK, Wanpy, Nature Bridge, WET NOSES
Apex Research, recently published a detailed market research study focused on the "Cat Wet Food Market" across the global, regional and country level. The report provides 360° analysis of "Cat Wet Food Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cat Wet Food industry, and estimates the future trend of Cat…
Emerging Opportunities in Wet Macular Degeneration Market
Wet Macular Degeneration Market: Overview
Macular degeneration is a weakening or collapsed working of the eyes’ macula. Macula is the small area on the retinal surface covered by the light-sensitive tissue lining which is blackish area of the eye. This part of the retina is responsible for individual’s central vision, allows viewing fine objects clearly. Generally old aged people develop macular degeneration because of natural aging process of the body. There…
